Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin

Mineralization and its effect on tumor targetability in vivo

Hwa Seung Han, Jungmin Lee, Hyun Ryoung Kim, Su Young Chae, Minwoo Kim, Gurusamy Saravanakumar, Hong Yeol Yoon, Dong Gil You, Hyewon Ko, Kwang Meyung Kim, Ick Chan Kwon, Jae Chan Park, Jae Hyung Park

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7 ± 4.5 nm) than bare PEG-HANPs (265.1 ± 9.5 nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (< pH 6.5), their sizes increased rapidly due to dissolution of the inorganic minerals. Doxorubicin (DOX), chosen as the model anticancer drug, was effectively encapsulated into the bare and mineralized nanoparticles. For bare PEG-HANPs, DOX was released in a sustained manner and its release rate was not dependent on the pH of the solution. On the other hand, DOX release from M-PEG-HANPs was pH-dependent: i.e. DOX was slowly released from nanoparticles under physiological condition (pH 7.4), whereas its release rates were much higher at mildly acidic environments (< pH 6.5). From in vivo biodistribution study, it was found that M-PEG-HANPs could reach the tumor site more effectively than bare PEG-HANPs. The antitumor efficacy of DOX-loaded nanoparticles was evaluated after systemic administration into the tumor-bearing mice. Of the samples tested, the most effective antitumor efficacy was observed for DOX-loaded M-PEG-HANPs. Overall, these results suggest that M-PEG-HANPs could be a promising carrier for an anticancer drug.

Original languageEnglish
Pages (from-to)105-114
Number of pages10
JournalJournal of Controlled Release
Volume168
Issue number2
DOIs
Publication statusPublished - 2013 Jun 10
Externally publishedYes

Fingerprint

Hyaluronic Acid
Nanoparticles
Doxorubicin
Ethylene Glycol
Neoplasms
Drug Carriers
Pharmaceutical Preparations

Keywords

  • Doxorubicin
  • Hyaluronic acid
  • Mineralization
  • Nanoparticles
  • Stability

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin : Mineralization and its effect on tumor targetability in vivo. / Han, Hwa Seung; Lee, Jungmin; Kim, Hyun Ryoung; Chae, Su Young; Kim, Minwoo; Saravanakumar, Gurusamy; Yoon, Hong Yeol; You, Dong Gil; Ko, Hyewon; Kim, Kwang Meyung; Kwon, Ick Chan; Park, Jae Chan; Park, Jae Hyung.

In: Journal of Controlled Release, Vol. 168, No. 2, 10.06.2013, p. 105-114.

Research output: Contribution to journalArticle

Han, HS, Lee, J, Kim, HR, Chae, SY, Kim, M, Saravanakumar, G, Yoon, HY, You, DG, Ko, H, Kim, KM, Kwon, IC, Park, JC & Park, JH 2013, 'Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: Mineralization and its effect on tumor targetability in vivo', Journal of Controlled Release, vol. 168, no. 2, pp. 105-114. https://doi.org/10.1016/j.jconrel.2013.02.022
Han, Hwa Seung ; Lee, Jungmin ; Kim, Hyun Ryoung ; Chae, Su Young ; Kim, Minwoo ; Saravanakumar, Gurusamy ; Yoon, Hong Yeol ; You, Dong Gil ; Ko, Hyewon ; Kim, Kwang Meyung ; Kwon, Ick Chan ; Park, Jae Chan ; Park, Jae Hyung. / Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin : Mineralization and its effect on tumor targetability in vivo. In: Journal of Controlled Release. 2013 ; Vol. 168, No. 2. pp. 105-114.
@article{05fc1d89c3a44c058782edbf4b2afeff,
title = "Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: Mineralization and its effect on tumor targetability in vivo",
abstract = "The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7 ± 4.5 nm) than bare PEG-HANPs (265.1 ± 9.5 nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (< pH 6.5), their sizes increased rapidly due to dissolution of the inorganic minerals. Doxorubicin (DOX), chosen as the model anticancer drug, was effectively encapsulated into the bare and mineralized nanoparticles. For bare PEG-HANPs, DOX was released in a sustained manner and its release rate was not dependent on the pH of the solution. On the other hand, DOX release from M-PEG-HANPs was pH-dependent: i.e. DOX was slowly released from nanoparticles under physiological condition (pH 7.4), whereas its release rates were much higher at mildly acidic environments (< pH 6.5). From in vivo biodistribution study, it was found that M-PEG-HANPs could reach the tumor site more effectively than bare PEG-HANPs. The antitumor efficacy of DOX-loaded nanoparticles was evaluated after systemic administration into the tumor-bearing mice. Of the samples tested, the most effective antitumor efficacy was observed for DOX-loaded M-PEG-HANPs. Overall, these results suggest that M-PEG-HANPs could be a promising carrier for an anticancer drug.",
keywords = "Doxorubicin, Hyaluronic acid, Mineralization, Nanoparticles, Stability",
author = "Han, {Hwa Seung} and Jungmin Lee and Kim, {Hyun Ryoung} and Chae, {Su Young} and Minwoo Kim and Gurusamy Saravanakumar and Yoon, {Hong Yeol} and You, {Dong Gil} and Hyewon Ko and Kim, {Kwang Meyung} and Kwon, {Ick Chan} and Park, {Jae Chan} and Park, {Jae Hyung}",
year = "2013",
month = "6",
day = "10",
doi = "10.1016/j.jconrel.2013.02.022",
language = "English",
volume = "168",
pages = "105--114",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin

T2 - Mineralization and its effect on tumor targetability in vivo

AU - Han, Hwa Seung

AU - Lee, Jungmin

AU - Kim, Hyun Ryoung

AU - Chae, Su Young

AU - Kim, Minwoo

AU - Saravanakumar, Gurusamy

AU - Yoon, Hong Yeol

AU - You, Dong Gil

AU - Ko, Hyewon

AU - Kim, Kwang Meyung

AU - Kwon, Ick Chan

AU - Park, Jae Chan

AU - Park, Jae Hyung

PY - 2013/6/10

Y1 - 2013/6/10

N2 - The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7 ± 4.5 nm) than bare PEG-HANPs (265.1 ± 9.5 nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (< pH 6.5), their sizes increased rapidly due to dissolution of the inorganic minerals. Doxorubicin (DOX), chosen as the model anticancer drug, was effectively encapsulated into the bare and mineralized nanoparticles. For bare PEG-HANPs, DOX was released in a sustained manner and its release rate was not dependent on the pH of the solution. On the other hand, DOX release from M-PEG-HANPs was pH-dependent: i.e. DOX was slowly released from nanoparticles under physiological condition (pH 7.4), whereas its release rates were much higher at mildly acidic environments (< pH 6.5). From in vivo biodistribution study, it was found that M-PEG-HANPs could reach the tumor site more effectively than bare PEG-HANPs. The antitumor efficacy of DOX-loaded nanoparticles was evaluated after systemic administration into the tumor-bearing mice. Of the samples tested, the most effective antitumor efficacy was observed for DOX-loaded M-PEG-HANPs. Overall, these results suggest that M-PEG-HANPs could be a promising carrier for an anticancer drug.

AB - The in vivo stability and tumor targetability of self-assembled polymeric nanoparticles are crucial for effective drug delivery. In this study, to develop biostable nanoparticles with high tumor targetability, poly(ethylene glycol)-conjugated hyaluronic acid nanoparticles (PEG-HANPs) were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method. The resulting nanoparticles (M-PEG-HANPs) had a smaller size (153.7 ± 4.5 nm) than bare PEG-HANPs (265.1 ± 9.5 nm), implying that mineralization allows the formation of compact nanoparticles. Interestingly, when the mineralized nanoparticles were exposed to acidic buffer conditions (< pH 6.5), their sizes increased rapidly due to dissolution of the inorganic minerals. Doxorubicin (DOX), chosen as the model anticancer drug, was effectively encapsulated into the bare and mineralized nanoparticles. For bare PEG-HANPs, DOX was released in a sustained manner and its release rate was not dependent on the pH of the solution. On the other hand, DOX release from M-PEG-HANPs was pH-dependent: i.e. DOX was slowly released from nanoparticles under physiological condition (pH 7.4), whereas its release rates were much higher at mildly acidic environments (< pH 6.5). From in vivo biodistribution study, it was found that M-PEG-HANPs could reach the tumor site more effectively than bare PEG-HANPs. The antitumor efficacy of DOX-loaded nanoparticles was evaluated after systemic administration into the tumor-bearing mice. Of the samples tested, the most effective antitumor efficacy was observed for DOX-loaded M-PEG-HANPs. Overall, these results suggest that M-PEG-HANPs could be a promising carrier for an anticancer drug.

KW - Doxorubicin

KW - Hyaluronic acid

KW - Mineralization

KW - Nanoparticles

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=84876190170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876190170&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2013.02.022

DO - 10.1016/j.jconrel.2013.02.022

M3 - Article

VL - 168

SP - 105

EP - 114

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -